The medicine sector in India presents a complex landscape, increasingly marked by concerns surrounding concentrated power. While the nation boasts a vibrant generic market, a few major companies maintain a disproportionate share of the market , sparking questions about rivalry and patient access to affordable treatments. This circumstance is fueled

The pharmaceutical landscape in India is increasingly characterized by a appearance toward market consolidation, with a handful of large companies wielding significant power. These business giants, often bolstered by long-standing distribution networks and considerable brand recognition, present a complex picture for competition and accessible heal

The Indian pharmaceutical industry, known for its affordable and accessible medicines, faces increasing concerns about monopolies. A few dominant firms control a significant portion of the market, potentially hampering competition and driving up prices for consumers. This situation raises worries about the long-term impact on patient access to aff